Clinical Research Directory

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Sponsor: Adverum Biotechnologies, Inc.

Summary

This is a prospective, observational study designed to evaluate the long-term safety and tolerability of ADVM-022 in participants with diabetic macular edema (DME). Participants who previously participated in the INFINITY parent study and received a single unilateral intravitreal dose of ADVM-022 are eligible for enrollment upon completion of the end of study visit in the parent study.

Official title: A Long-Term Follow-Up Study of ADVM-022 in Diabetic Macular Edema- INFINITY Extension

Key Details

Conditions

Interventions

Locations (7)